Methods and systems for genetic analysis of fetal nucleated red blood cells
AssigneeCellscape Corporation
InventorsBhairavi Parikh, James Stone, Michael D. Brody, Vivek Balasubramanyam, Jonathan D. Halderman
Life of this patent
Estimating the term…
Loading patent…
AssigneeCellscape Corporation
InventorsBhairavi Parikh, James Stone, Michael D. Brody, Vivek Balasubramanyam, Jonathan D. Halderman
Estimating the term…
Methods for determining genetic status of a fetus from a sample of maternal blood comprise enriching nucleated red blood cells in the sample, including both fetal and maternal nucleated red blood cells. The nucleated red blood cells are then differentiated from all other blood cells in the enriched sample, and the nucleated red blood cells genetically screened to determine the genetic status. The nucleated red blood cells may be differentiated by immobilizing all enriched blood cells on a solid phase and locating the nucleated red blood cells for interrogation. Optionally, the nucleated red blood cells may be sorted and separated from other enriched blood cells in a liquid phase.
A method for determining genetic status of a fetus, said method comprising;
A method for identifying an increased risk of abnormal pregnancy in a pregnant female, said method comprising;
Dependencies are inferred from the claim text.